Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials

INTRODUCTION: The objective of this study was to evaluate the effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on serum magnesium in hypomagnesemic patients with type 2 diabetes. METHODS: This post hoc analysis was based on pooled data from four placebo-controlled studies of ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilbert, Richard E., Mende, Christian, Vijapurkar, Ujjwala, Sha, Sue, Davies, Michael J., Desai, Mehul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380494/
https://www.ncbi.nlm.nih.gov/pubmed/28197834
http://dx.doi.org/10.1007/s13300-017-0232-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380494/
https://www.ncbi.nlm.nih.gov/pubmed/28197834
http://dx.doi.org/10.1007/s13300-017-0232-0

Ejemplares similares